References
Cher ML, Bianco FJ Jr, Lam JS, Davis LP, Grignon DJ, Sakr WA, et al. Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol 1998;160:1387–91.
Nanni C, Farsad M, Zamagni E, Castellucci P, Cangini D, Montini G, et al. Evaluation of bone lesions in patients with multiple myeloma: comparison between 18F-FDG PET/CT and 11C-Choline PET/CT. Eur J Nucl Med Mol Imaging 2006;33 Suppl 2:188.
Cimitan M, Borsatti E, Tatta R, Drigo A, Rampin L, Rubello D. Uptake of 18F-Fluorocholine (FCH) by bone metastases of prostate cancer: what’s the best timing for PET FCH acquisition? J Nucl Med 2005;46 Suppl 2:432.
Cimitan M, Borsatti E, Tatta R, Drigo A, Rampin L, Rubello D. Timing for 18F-fluorocholine PET/CT acquisition in patients with metastatic prostate cancer. Eur J Nucl Med Mol Imaging 2005;32 Suppl 1:160.
Author information
Authors and Affiliations
Corresponding author
Additional information
This reply refers to the letter to the editor at http://dx.doi.org/10.1007/s00259-007-0401-x
Rights and permissions
About this article
Cite this article
Cimitan, M., Bortolus, R., Morassut, S. et al. Reply. Eur J Nucl Med Mol Imaging 34, 1318–1319 (2007). https://doi.org/10.1007/s00259-007-0402-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-007-0402-9